Developer docs
API playgroundTry for free, no card

Search company profiles

Imprivata

Full company profile

uuid0005tmo

Namestring
Imprivata
Legal namestring
Imprivata, Inc.
Websiteurl
imprivata.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Imprivata is a digital identity and access management company purpose-built for healthcare and other life- and mission-critical industries. Founded in 2002 and headquartered in Waltham, Massachusetts, the company delivers a unified Enterprise Access Management platform that combines single sign-on (SSO), multifactor authentication (MFA), passwordless and facial biometric authentication, privileged access management (PAM), and AI-powered behavioral analytics. It sells primarily to hospitals, health systems, and clinical workforces that require frictionless yet compliant access to electronic health records (EHRs) and shared clinical workstations, with named customers including PennState Health, Seattle Children's, BayCare, Atrium Health, Cambridge Health Alliance, and 55 UK/Ireland hospitals.

The platform is built on integrations with Epic (native in Epic Toolbox and App Orchard), SailPoint, Netskope, Google Chrome Enterprise Premium, and IGEL, and has been expanded through acquisitions including Xton Technologies (PAM, 2021), SecureLink (vendor PAM, 2022), OGiTiX (2022), and Verosint (ITDR, 2025). Healthcare-specific modules include Patient Privacy Intelligence, Drug Diversion Intelligence, Medical Device Access Management, and Imprivata Patient Access, while a 2026 launch of Agentic Identity Management extends the platform to govern AI agents operating in clinical environments. Certifications cover HIPAA, HITECH, DEA-EPCS (21 CFR Part 1311), FIDO, ISO 27001:2022, ISO 27701:2019, SOC 2 Type 1 & 2, Cyber Essentials Plus, GDPR, and the EU/U.S./UK Data Privacy Frameworks.

Imprivata operates a subscription-based enterprise SaaS model with quote-based multi-year contracts, tiered maintenance and support, professional services, and hardware appliance sales. The company is privately held by Thoma Bravo (acquired in 2016 for approximately $544 million), serves 4,000+ organizations and 4M+ users globally across the Americas, EMEA, and APAC, and generates approximately $500 million in annual revenue. As of January 2026, Thoma Bravo is exploring a sale of the company at a potential valuation of up to $7 billion, with JPMorgan and Evercore advising on the early-stage process.

Short descriptiontext

Imprivata provides digital identity and access management software (SSO, MFA, passwordless, PAM, and AI-driven behavioral analytics) purpose-built for hospitals, health systems, and other mission-critical industries, serving 4,000+ organizations and 4M+ users globally under Thoma Bravo ownership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
identity access management, privileged access management, single sign-on, multifactor authentication, healthcare cybersecurity
Industry4 codes
PRIMARYBPAMAEAE
Authentication (MFA/Passwordless/Biometrics) Platforms
Business & Public Services/Web, Mobile & Digital Platforms/Digital Identity, Authentication & Access
SECONDARYHDAEAJAB
Single Sign-On (SSO) & Federation (SAML/OIDC, Identity Providers)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Identity & Access Management (IAM) & Directory Services Platforms
SECONDARYHDABAHAF
Cloud Identity & Access Management Infrastructure (IAM/IdP/MFA)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Cloud Security & Compliance Infrastructure
SECONDARYBPAKAHAI
Identity & Access Security Services (IAM, PAM, Zero Trust)
Business & Public Services/Security & Investigations Services/Cybersecurity & Digital Forensics Services
NAICS code2 codes
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Identity and Access Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Enterprise Access Management Subscription
TypeSubscription Recurring
Description

Subscription-based licensing for Enterprise Access Management platform including SSO, MFA, and passwordless authentication capabilities. Recurring annual or multi-year contracts with enterprise customers.

finimize.com
2Privileged Access Management
TypeSubscription Recurring
Description

PAM solutions sold as subscription or perpetual license with annual maintenance. Includes vendor and customer privileged access management modules.

finimize.com
3Maintenance and Support Services
TypeSubscription Recurring
Description

Annual maintenance and support contracts with tiered service levels (Standard, Premium). Fees based on list price with 12-month initial terms auto-renewing annually.

imprivata.com
4Professional Services
TypeProfessional Services
Description

Fee-based custom development, implementation services, and training including Imprivata Certified Engineer (ICE) training programs.

imprivata.com
5Hardware Sales
TypeHardware Sales
Description

Sale of Imprivata-branded hardware appliances with 12-month warranty. Replacement and upgrade hardware priced at current list price.

imprivata.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Standard Maintenance and Support
ModelSubscriptionBilling cadenceAnnual
Notes

Includes support during business hours, maintenance releases, and access to Support and Learning Center. Named Support Contacts limited based on license count.

imprivata.com
2Premium Maintenance and Support
ModelSubscriptionBilling cadenceAnnual
Notes

24/7 support availability for Priority 1 issues, faster response times, and extended support hours.

imprivata.com
3Enterprise Access Management Platform
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based pricing for enterprise deployment including SSO, MFA, passwordless authentication, and analytics capabilities. Pricing varies by organization size and deployment scope.

finimize.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 9 records shown
1Imprivata Enterprise Access Management
Description

Unified access management platform providing passwordless authentication, SSO, and MFA for enterprise users

imprivata.com
+8 more records
Core offering1 text field

Imprivata develops and sells a unified digital identity and access management platform for healthcare and other mission-critical industries. Its core offerings include Enterprise Access Management (EAM) with single sign-on, multifactor authentication, passwordless authentication, and mobile device access, complemented by Privileged Access Management, vendor/customer privileged access, patient biometric authentication, and AI-driven patient privacy and drug diversion monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 3.3 million clinician hours redirected annually from logging in to patient care across 55 UK and Ireland hospitals
+2 more records
Product overview1 text field

Imprivata offers a unified Enterprise Access Management platform for healthcare and mission-critical industries, combining core access management capabilities with specialized healthcare and security modules. The core Enterprise Access Management platform provides passwordless authentication, Single Sign-On, and Multifactor Authentication as foundational capabilities. Specialized healthcare modules include Patient Privacy Intelligence and Drug Diversion Intelligence for monitoring anomalous access behaviors, Medical Device Access Management, and Patient Access for biometric authentication. Third-party and privileged access is addressed through Vendor Privileged Access Management (from SecureLink acquisition) and Privileged Access Management (expanded through Xton Technologies acquisition). The 2026 Agentic Identity Management platform extends the portfolio to secure and govern AI agents. Identity Threat Detection and Response from Verosint provides AI-powered risk signaling. Access Compliance delivers AI-powered analytics for compliance monitoring. All capabilities are unified under a single platform approach designed to consolidate multiple access tools for improved security and reduced total cost of ownership.

Product and service14 records
1Enterprise Access Management (EAM)
2Single Sign-On (SSO)
CategoryAccess Management Module
Description

Core SSO capability enabling frictionless, secure single sign-on for healthcare and enterprise applications, redirecting clinician hours from logging in to patient care.

3Multifactor Authentication (MFA)
CategoryAccess Management Module
Description

MFA solution providing additional security layer for enterprise access, supporting various authentication methods including biometrics, tokens, and mobile credentials, with DEA-EPCS compliance for electronic prescribing of controlled substances.

4Mobile Access
CategoryMobile Device Access
Description

End-to-end enterprise mobility solution helping organizations optimize use of shared iOS and Android mobile devices in healthcare and other regulated environments.

5Privileged Access Management (PAM)
CategoryPrivileged Access
Description

PAM solution providing access governance for highly privileged users, securing internal access to critical systems and data for healthcare and enterprise organizations.

6Vendor Privileged Access Management
CategoryPrivileged Access
Description

Third-party access control solution securing digital identities and remote access to control and monitor how vendors connect and use critical systems and data, originally from SecureLink acquisition.

7Customer Privileged Access Management (Remote Support)
CategoryPrivileged Access
Description

Remote support solution for privileged access management of customer environments, enabling secure vendor access and monitoring.

8Patient Access (Biometric Patient Authentication)
9Agentic Identity Management
10Identity Threat Detection and Response (ITDR / Verosint)
11Patient Privacy Intelligence
12Drug Diversion Intelligence
13Medical Device Access Management
14Professional Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-30
Description

Integration partner recognized as IGEL Ready Partner of the Year 2026. Imprivata integrated with IGEL Adaptive Secure Endpoint Platform for enterprise cloud solutions and secure digital workspaces.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-03-03
Description

SaaS integration combining Imprivata's passwordless authentication with Netskope's Zero Trust Engine for identity-aware security and HIPAA/HITECH compliance on shared clinical workstations.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-18
Description

Imprivata Patient Access launched as native integration in Epic Toolbox using facial recognition and IAL2 standards to allow patients secure MyChart account creation without activation codes.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-14
Description

Identity Threat Detection and Response (ITDR) firm specializing in continuous monitoring for anomalous access behavior. Acquisition completed to integrate AI-powered risk signaling into Imprivata's enterprise access management platform.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-19
Description

Joint solution combining SailPoint and Imprivata technologies to improve access management, reduce cyber risks, and enhance compliance for organizations with frontline workers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-27
Description

Strategic partnership combining SailPoint's identity governance with Imprivata's access management to improve access management and reduce cyber risks in healthcare organizations. SailPoint named Best in KLAS 2025 in Identity Management.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-04-11
Description

Critical access management provider acquired by Imprivata with Thoma Bravo backing. Cove Hill Partners retained minority stake. SecureLink provided vendor privileged access management solutions.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-07-08
Description

Privileged access management solutions provider acquired to enhance Imprivata's digital identity platform for healthcare and enterprise organizations with access governance for highly privileged users.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Okta is a leading cloud-native identity and access management platform offering SSO, MFA, lifecycle management, and adaptive authentication. It directly competes with Imprivata in enterprise healthcare IAM and broader workforce identity use cases.

TypeBroad incumbent
Description

Microsoft Entra ID (formerly Azure AD) is a broad incumbent identity platform bundled with Microsoft 365 and widely deployed in healthcare systems. It competes on price-bundled IAM and is a key threat to standalone IAM vendors like Imprivata.

TypeDirect peer
Description

Ping Identity provides enterprise SSO, MFA, and identity federation with strong healthcare and regulated-industry penetration. It is a direct competitor to Imprivata's Enterprise Access Management platform in workforce and patient identity scenarios.

TypeDirect peer
Description

CyberArk is a leader in privileged access management (PAM), competing directly with Imprivata's PAM module (built from Xton and SecureLink acquisitions). CyberArk's identity security platform overlaps significantly with Imprivata's privileged access offerings.

TypeDirect peer
Description

SailPoint is a leading identity governance and administration (IGA) vendor and a strategic partner of Imprivata. It is also a competitor in identity lifecycle and access governance, named Best in KLAS 2025 in Identity Management for healthcare.

TypeDirect peer
Description

BeyondTrust provides privileged access management and vulnerability management solutions, competing with Imprivata's PAM and vendor privileged access offerings in enterprise and healthcare markets.

TypeDirect peer
Description

One Identity (Quest) and OneLogin offer IAM, IGA, and PAM solutions that compete with Imprivata's portfolio in workforce identity, especially in mid-market and regulated industries.

TypeEmerging player
Description

HID Global provides identity and access management solutions including physical and logical access, biometric authentication, and credentialing. It overlaps with Imprivata's biometric authentication and identity verification capabilities.

TypeEmerging player
Description

Verkada is a security platform that has been expanding from physical security into identity and access controls; it represents an emerging player that could compete with Imprivata in shared device and facility access scenarios.

TypeEmerging player
Description

Transmit Security offers passwordless authentication, fraud prevention, and identity verification APIs. It is an emerging player in the broader passwordless and biometric authentication space where Imprivata is also active.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance12 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Imprivata

Identity and Access Managementimprivata.com

Imprivata provides digital identity and access management software (SSO, MFA, passwordless, PAM, and AI-driven behavioral analytics) purpose-built for hospitals, health systems, and other mission-critical industries, serving 4,000+ organizations and 4M+ users globally under Thoma Bravo ownership.

What Imprivata does

Imprivata is a digital identity and access management company purpose-built for healthcare and other life- and mission-critical industries. Founded in 2002 and headquartered in Waltham, Massachusetts, the company delivers a unified Enterprise Access Management platform that combines single sign-on (SSO), multifactor authentication (MFA), passwordless and facial biometric authentication, privileged access management (PAM), and AI-powered behavioral analytics. It sells primarily to hospitals, health systems, and clinical workforces that require frictionless yet compliant access to electronic health records (EHRs) and shared clinical workstations, with named customers including PennState Health, Seattle Children's, BayCare, Atrium Health, Cambridge Health Alliance, and 55 UK/Ireland hospitals.

The platform is built on integrations with Epic (native in Epic Toolbox and App Orchard), SailPoint, Netskope, Google Chrome Enterprise Premium, and IGEL, and has been expanded through acquisitions including Xton Technologies (PAM, 2021), SecureLink (vendor PAM, 2022), OGiTiX (2022), and Verosint (ITDR, 2025). Healthcare-specific modules include Patient Privacy Intelligence, Drug Diversion Intelligence, Medical Device Access Management, and Imprivata Patient Access, while a 2026 launch of Agentic Identity Management extends the platform to govern AI agents operating in clinical environments. Certifications cover HIPAA, HITECH, DEA-EPCS (21 CFR Part 1311), FIDO, ISO 27001:2022, ISO 27701:2019, SOC 2 Type 1 & 2, Cyber Essentials Plus, GDPR, and the EU/U.S./UK Data Privacy Frameworks.

Imprivata operates a subscription-based enterprise SaaS model with quote-based multi-year contracts, tiered maintenance and support, professional services, and hardware appliance sales. The company is privately held by Thoma Bravo (acquired in 2016 for approximately $544 million), serves 4,000+ organizations and 4M+ users globally across the Americas, EMEA, and APAC, and generates approximately $500 million in annual revenue. As of January 2026, Thoma Bravo is exploring a sale of the company at a potential valuation of up to $7 billion, with JPMorgan and Evercore advising on the early-stage process.

Imprivata firmographics

Firmographics
Name
Imprivata
Legal name
Imprivata, Inc.
Website
https://imprivata.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Imprivata provides digital identity and access management software (SSO, MFA, passwordless, PAM, and AI-driven behavioral analytics) purpose-built for hospitals, health systems, and other mission-critical industries, serving 4,000+ organizations and 4M+ users globally under Thoma Bravo ownership.
Ownership category
akta.pro rank

Imprivata industry classification

Industry
Product category
Identity and Access Management
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYBPAMAEAE
Authentication (MFA/Passwordless/Biometrics) Platforms
Business & Public Services/Web, Mobile & Digital Platforms/Digital Identity, Authentication & Access
SECONDARYHDAEAJAB
Single Sign-On (SSO) & Federation (SAML/OIDC, Identity Providers)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Identity & Access Management (IAM) & Directory Services Platforms
SECONDARYHDABAHAF
Cloud Identity & Access Management Infrastructure (IAM/IdP/MFA)
Hardware, Technology & Telecom/Cloud & Data Center Infrastructure/Cloud Security & Compliance Infrastructure
SECONDARYBPAKAHAI
Identity & Access Security Services (IAM, PAM, Zero Trust)
Business & Public Services/Security & Investigations Services/Cybersecurity & Digital Forensics Services

Keywords

  • Identity access management
  • Privileged access management
  • Single sign-on
  • Multifactor authentication
  • Healthcare cybersecurity

Where Imprivata is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Imprivata business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise Access Management Subscription: Subscription-based licensing for Enterprise Access Management platform including SSO, MFA, and passwordless authentication capabilities. Recurring annual or multi-year contracts with enterprise customers.
  2. Privileged Access Management: PAM solutions sold as subscription or perpetual license with annual maintenance. Includes vendor and customer privileged access management modules.
  3. Maintenance and Support Services: Annual maintenance and support contracts with tiered service levels (Standard, Premium). Fees based on list price with 12-month initial terms auto-renewing annually.
  4. Professional Services: Fee-based custom development, implementation services, and training including Imprivata Certified Engineer (ICE) training programs.
  5. Hardware Sales: Sale of Imprivata-branded hardware appliances with 12-month warranty. Replacement and upgrade hardware priced at current list price.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard Maintenance and Support
SubscriptionAnnualPremium Maintenance and Support
SubscriptionMulti-year contractEnterprise Access Management Platform

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Imprivata product offering

Product offering

Core offering

Imprivata develops and sells a unified digital identity and access management platform for healthcare and other mission-critical industries. Its core offerings include Enterprise Access Management (EAM) with single sign-on, multifactor authentication, passwordless authentication, and mobile device access, complemented by Privileged Access Management, vendor/customer privileged access, patient biometric authentication, and AI-driven patient privacy and drug diversion monitoring.

Product overview

Imprivata offers a unified Enterprise Access Management platform for healthcare and mission-critical industries, combining core access management capabilities with specialized healthcare and security modules. The core Enterprise Access Management platform provides passwordless authentication, Single Sign-On, and Multifactor Authentication as foundational capabilities. Specialized healthcare modules include Patient Privacy Intelligence and Drug Diversion Intelligence for monitoring anomalous access behaviors, Medical Device Access Management, and Patient Access for biometric authentication. Third-party and privileged access is addressed through Vendor Privileged Access Management (from SecureLink acquisition) and Privileged Access Management (expanded through Xton Technologies acquisition). The 2026 Agentic Identity Management platform extends the portfolio to secure and govern AI agents. Identity Threat Detection and Response from Verosint provides AI-powered risk signaling. Access Compliance delivers AI-powered analytics for compliance monitoring. All capabilities are unified under a single platform approach designed to consolidate multiple access tools for improved security and reduced total cost of ownership.

Differentiator

Problem solved

Functional benefit

Brands

  • Imprivata Enterprise Access Management: Unified access management platform providing passwordless authentication, SSO, and MFA for enterprise users
  • Imprivata Patient Access
  • Imprivata Agentic Identity Management
  • Verosint
  • FairWarning
  • GroundControl
  • OneSign
  • ConfirmID
  • Imprivata OGiTiX

Products and services

  • Enterprise Access Management (EAM)
  • Single Sign-On (SSO) Core SSO capability enabling frictionless, secure single sign-on for healthcare and enterprise applications, redirecting clinician hours from logging in to patient care.
  • Multifactor Authentication (MFA) MFA solution providing additional security layer for enterprise access, supporting various authentication methods including biometrics, tokens, and mobile credentials, with DEA-EPCS compliance for electronic prescribing of controlled substances.
  • Mobile Access End-to-end enterprise mobility solution helping organizations optimize use of shared iOS and Android mobile devices in healthcare and other regulated environments.
  • Privileged Access Management (PAM) PAM solution providing access governance for highly privileged users, securing internal access to critical systems and data for healthcare and enterprise organizations.
  • Vendor Privileged Access Management Third-party access control solution securing digital identities and remote access to control and monitor how vendors connect and use critical systems and data, originally from SecureLink acquisition.
  • Customer Privileged Access Management (Remote Support) Remote support solution for privileged access management of customer environments, enabling secure vendor access and monitoring.
  • Patient Access (Biometric Patient Authentication)
  • Agentic Identity Management
  • Identity Threat Detection and Response (ITDR / Verosint)
  • Patient Privacy Intelligence
  • Drug Diversion Intelligence
  • Medical Device Access Management
  • Professional Services

Quantifiable outcome

  • 3.3 million clinician hours redirected annually from logging in to patient care across 55 UK and Ireland hospitals
  • +2 more outcomes

Companies that use Imprivata

Customer profile

Named customers9 records

Segments6 records

Ideal customer profiles2 records

Imprivata technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature7 records

Imprivata partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • IGELcoreTechnology or Integration · 30 March 2026Integration partner recognized as IGEL Ready Partner of the Year 2026. Imprivata integrated with IGEL Adaptive Secure Endpoint Platform for enterprise cloud solutions and secure digital workspaces.
  • NetskopecoreTechnology or Integration · 3 March 2026SaaS integration combining Imprivata's passwordless authentication with Netskope's Zero Trust Engine for identity-aware security and HIPAA/HITECH compliance on shared clinical workstations.
  • Epic SystemscoreTechnology or Integration · 18 February 2026Imprivata Patient Access launched as native integration in Epic Toolbox using facial recognition and IAL2 standards to allow patients secure MyChart account creation without activation codes.
  • VerosintcoreTechnology or Integration · 14 October 2025Identity Threat Detection and Response (ITDR) firm specializing in continuous monitoring for anomalous access behavior. Acquisition completed to integrate AI-powered risk signaling into Imprivata's enterprise access management platform.
  • SailPointcoreTechnology or Integration · 19 August 2025Joint solution combining SailPoint and Imprivata technologies to improve access management, reduce cyber risks, and enhance compliance for organizations with frontline workers.
  • SailPointcoreStrategic or Co-development Partner · 27 February 2025Strategic partnership combining SailPoint's identity governance with Imprivata's access management to improve access management and reduce cyber risks in healthcare organizations. SailPoint named Best in KLAS 2025 in Identity Management.
  • SecureLinkcoreTechnology or Integration · 11 April 2022Critical access management provider acquired by Imprivata with Thoma Bravo backing. Cove Hill Partners retained minority stake. SecureLink provided vendor privileged access management solutions.
  • Xton TechnologiescoreTechnology or Integration · 8 July 2021Privileged access management solutions provider acquired to enhance Imprivata's digital identity platform for healthcare and enterprise organizations with access governance for highly privileged users.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Imprivata competitors and assessment

Company assessment

Direct peers

  • Okta: Okta is a leading cloud-native identity and access management platform offering SSO, MFA, lifecycle management, and adaptive authentication. It directly competes with Imprivata in enterprise healthcare IAM and broader workforce identity use cases.
  • Ping Identity: Ping Identity provides enterprise SSO, MFA, and identity federation with strong healthcare and regulated-industry penetration. It is a direct competitor to Imprivata's Enterprise Access Management platform in workforce and patient identity scenarios.
  • CyberArk: CyberArk is a leader in privileged access management (PAM), competing directly with Imprivata's PAM module (built from Xton and SecureLink acquisitions). CyberArk's identity security platform overlaps significantly with Imprivata's privileged access offerings.
  • SailPoint: SailPoint is a leading identity governance and administration (IGA) vendor and a strategic partner of Imprivata. It is also a competitor in identity lifecycle and access governance, named Best in KLAS 2025 in Identity Management for healthcare.
  • BeyondTrust: BeyondTrust provides privileged access management and vulnerability management solutions, competing with Imprivata's PAM and vendor privileged access offerings in enterprise and healthcare markets.
  • One Identity (OneLogin): One Identity (Quest) and OneLogin offer IAM, IGA, and PAM solutions that compete with Imprivata's portfolio in workforce identity, especially in mid-market and regulated industries.

Broad incumbents

  • Microsoft Entra ID: Microsoft Entra ID (formerly Azure AD) is a broad incumbent identity platform bundled with Microsoft 365 and widely deployed in healthcare systems. It competes on price-bundled IAM and is a key threat to standalone IAM vendors like Imprivata.

Emerging players

  • HID Global: HID Global provides identity and access management solutions including physical and logical access, biometric authentication, and credentialing. It overlaps with Imprivata's biometric authentication and identity verification capabilities.
  • Verkada: Verkada is a security platform that has been expanding from physical security into identity and access controls; it represents an emerging player that could compete with Imprivata in shared device and facility access scenarios.
  • Transmit Security: Transmit Security offers passwordless authentication, fraud prevention, and identity verification APIs. It is an emerging player in the broader passwordless and biometric authentication space where Imprivata is also active.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Imprivata social profiles

Digital presence

Imprivata compliance and trust

Trust signal

Compliance12 records

Imprivata financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Imprivata leadership team

Management profile

Number of profiles

Profiles11 records

Imprivata subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Imprivata funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Imprivata M&A and investment

M&A and investment

M&A9 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imprivata

What does Imprivata do?

Imprivata develops and sells a unified digital identity and access management platform for healthcare and other mission-critical industries. Its core offerings include Enterprise Access Management (EAM) with single sign-on, multifactor authentication, passwordless authentication, and mobile device access, complemented by Privileged Access Management, vendor/customer privileged access, patient biometric authentication, and AI-driven patient privacy and drug diversion monitoring.

Is Imprivata a public or private company?

Imprivata is a private company. It is classified as private equity controlled and is currently operating.

When was Imprivata founded?

Imprivata was founded in 2000. It employs 1,001 to 5,000 people.

Where is Imprivata based?

Imprivata is headquartered in Waltham, United States, in the North America region.

How does Imprivata make money?

Five revenue lines are on record. Enterprise Access Management Subscription is the primary driver. The others are privileged Access Management, maintenance and Support Services, professional Services and hardware Sales.

Who are Imprivata's main competitors?

Direct peers on record are Okta, Ping Identity, CyberArk, SailPoint, BeyondTrust and One Identity (OneLogin). Microsoft Entra ID is listed as a broad incumbent. Emerging players are HID Global, Verkada and Transmit Security.

Does Imprivata have an API?

Yes. Imprivata offers a partner-facing API license through its Technology Partner Program. The API license grants partners a non-transferable, non-exclusive, royalty-free license to internally use and reproduce the Imprivata Products API and developer tools solely for creating Interface Software to achieve interoperability between Partner Products and Imprivata Products, testing and demonstrating interoperability, and providing end user customer support. This is a restricted partner API, not publicly available. No public developer portal or documentation URL identified in the source data.

What industry is Imprivata in?

Imprivata's product category is Identity and Access Management. Its primary akta.pro industry code is BPAMAEAE, Authentication (MFA/Passwordless/Biometrics) Platforms, with a secondary code of HDAEAJAB, Single Sign-On (SSO) & Federation (SAML/OIDC, Identity Providers). Its NAICS code is 51821 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Forbes18 Outdated Identity And Access Management Assumptions To RetireThe article lists 18 outdated identity and access management assumptions, including that one-time verification is sufficient or that strong authentication alone secures identity. It argues for continuous verification, risk-based access, and per-use credentials, citing experts from companies like Veriff and Imprivata.Business & FinancialImprivata Wins 2026 Top Infosec Innovator Award For AI Security And GovernanceImprivata won the 2026 Top InfoSec Innovator Award for AI Security and Governance from Cyber Defense Magazine. The award recognizes its Agentic Identity Management solution, which treats AI agents as managed identities to secure access to critical systems. The company's product extends identity security principles to non-human identities.GlobeNewswireZugriff auf alle benötigten IT-Ressourcen ab dem ersten ArbeitstagImprivata introduced Day-one Access, a feature in its Enterprise Access Management solution, enabling new employees to access applications and resources on their first day. The feature automates access provisioning, eliminating temporary passwords and reducing IT and helpdesk workload. It supports passwordless multi-factor authentication and compliance with regulations like DSGVO and NIS2.MedTech DiveHealthcare’s agentic AI boom is outpacing governance: reportA new Imprivata survey finds healthcare organizations are adopting agentic AI faster than governance frameworks, with over 85% of leaders confident in visibility and control. Yet 72% admit AI tools are deployed without IT approval, and more than a quarter have implemented agentic AI. Experts warn of security risks and call for stronger oversight.Healthcare DiveHealthcare’s agentic AI boom is outpacing governance: reportA survey by Imprivata found healthcare leaders are confident in governing agentic AI, but 72% admit unapproved deployments occur. Over 25% have implemented agentic AI, with 44% piloting, while security concerns remain high. The report highlights a gap between confidence and reality in AI governance.HIT ConsultantImprivata Report Reveals 72% of Healthcare Organizations Run Unapproved AI as Autonomous Agents Enter Clinical CareImprivata's survey of 250 U.S. healthcare leaders found 72% deploy AI tools without formal IT approval, with 28% in production and 44% piloting. AI agents currently touch 33% of clinical workflows, projected to reach 41% in 12-18 months. The report highlights governance gaps and recommends identity-led controls.FierceHealthcareMost health systems deploy AI tools without formal IT approval. What are the risks?Nearly three-quarters of U.S. healthcare organizations deploy AI tools without formal IT approval, according to an Imprivata survey of 250 leaders. Over a quarter have agentic AI in production, and 79% expect it to transform clinical workflows, but only 17% find existing identity approaches sufficient. Imprivata recommends clear identity and monitoring controls rather than broad restrictions.Pharmaceutical TechnologyAgentic AI trust gap slowing healthcare provider adoption, survey reveals - Pharmaceutical TechnologyImprivata's survey of healthcare providers found 83% have deployed AI, but only 28% use agentic models, with 72% deploying them without formal IT approval. Governance and compliance issues are top barriers, and 44% are running proof-of-concept projects. Imprivata recommends defined rules, continuous monitoring, and human oversight for high-risk agents.Medical Device NetworkAgentic AI trust gap slowing healthcare provider adoption, survey revealsImprivata's survey of healthcare providers found 83% have deployed AI, but only 28% use agentic models, with 72% deploying them without formal IT approval. Governance and compliance issues are top barriers, and 44% are running proof-of-concept projects. Imprivata recommends defined rules, continuous monitoring, and human oversight for high-risk agents.MedCity NewsImprivata CEO: AI Agents Need the Same Scrutiny as an Unvetted Contract NurseImprivata CEO Fran Rosch proposed treating AI agents like unvetted contract nurses, requiring vetting, monitoring, and revocation of access. The company extends its existing privileged access security gateway to govern agents, with about a dozen health systems testing the approach. Rosch expects the model to become industry standard once health systems budget for it.